tiprankstipranks
BioVersys AG (CH:BIOV)
:BIOV
Switzerland Market

Compare BioVersys AG (BIOV) vs. Competitors

2 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
BioVersys AG
CHF26.50
CHF154.99M
-6.80
-23.63%
2 Buy
0 Hold
0 Sell
Moderate Buy
Molecular Partners AG
$2.25
$172.25M
-2.50
-49.62%
1 Buy
0 Hold
0 Sell
Moderate Buy
Basilea Pharmaceutica
CHF52.60
CHF664.04M
16.63
36.93%
1 Buy
0 Hold
0 Sell
Moderate Buy
Newron Pharmaceuticals SpA
$20.00
$394.98M
-9.69
113.68%
1 Buy
0 Hold
0 Sell
Moderate Buy
Santhera Pharmaceuticals Holding
$21.40
$298.20M
-0.98
35.02%
1 Buy
0 Hold
0 Sell
Moderate Buy
RELIEF THERAPEUTICS Holding
$1.88
$59.28M
-1.50
-86.22%

Performance Comparison

Ticker
Company Name
Price
Change
% Change
CH:BIOV
BioVersys AG
26.50
-7.10
-21.13%
MLLCF
Molecular Partners AG
2.33
-2.30
-49.62%
CH:BSLN
Basilea Pharmaceutica
54.50
13.45
32.76%
NWPHF
Newron Pharmaceuticals SpA
20.00
10.64
113.68%
SPHDF
Santhera Pharmaceuticals Holding
21.40
4.95
30.09%
RLFTF
RELIEF THERAPEUTICS Holding
0.38
-2.52
-86.93%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts